Last updated on August 2019

Safety PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

Brief description of study

This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza. Two thirds of the participants will receive peramivir, while one third will receive oseltamivir.

Clinical Study Identifier: NCT02369159

Find a site near you

Start Over

Peramivir Investigative Site

Shreveport, LA United States
  Connect »